U.S. Water Utilities Stock News

NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Cytokinetics (CYTK) Quarterly Loss Of US$183 Million Reinforces Bearish Profitability Concerns

Cytokinetics (CYTK) has capped FY 2025 with Q4 revenue of US$17.8 million and a basic EPS loss of US$1.52, anchored by a net loss of US$183.0 million. This sets the tone for how investors are reading the latest update against a year of heavy spending. Over recent periods, the company has seen quarterly revenue range from US$1.6 million to US$66.8 million in FY 2025, while basic EPS losses have moved between US$1.12 and US$2.55. This gives a clear picture of a business that is still investing...
NYSE:LTC
NYSE:LTCHealth Care REITs

LTC Properties (LTC) Dividend Coverage Concerns Challenge Bullish Growth Narratives

LTC Properties FY 2025 Earnings Snapshot LTC Properties (LTC) has wrapped up FY 2025 with fourth quarter total revenue of US$84.3 million and basic EPS of US$2.13, supported by funds from operations of US$34.5 million and FFO per share of US$0.72, alongside trailing 12 month EPS of US$2.54 on revenue of US$262.9 million. Over recent periods, the company has seen total revenue move from US$51.9 million in Q4 2024 to US$84.3 million in Q4 2025, while basic EPS shifted from US$0.40 in Q4 2024 to...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Is There Now an Opportunity in Expedia Group (EXPE) After the Recent Share Price Pullback

If you are wondering whether Expedia Group's share price reflects its real worth today, you are not alone. This article will walk through what the current market price might be implying about the company. After a long term return of 93.5% over 3 years and 25.7% over 5 years, the stock has recently pulled back, with a 24.4% decline over 30 days and a 28.0% decline year to date from a last close of US$203.74. This may have shifted how the market is thinking about its future. Recent headlines...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Acadia Healthcare Company (ACHC) Posts Q4 US$1.18b Loss Testing Bullish Margin Narratives

Acadia Healthcare Company (ACHC) just wrapped up FY 2025 with Q4 revenue of US$821.5 million and a basic EPS loss of US$13.02, alongside a trailing 12-month basic EPS loss of US$12.16 on revenue of about US$3.3 billion. The company has seen quarterly revenue move from US$774.2 million in Q4 2024 to US$770.5 million in Q1 2025, US$869.2 million in Q2, US$851.6 million in Q3, and US$821.5 million in Q4, while basic EPS shifted from US$0.36 in Q4 2024 to US$0.09, US$0.33, and US$0.40 through the...
NasdaqGS:RGEN
NasdaqGS:RGENLife Sciences

Assessing Repligen (RGEN) After Prolonged Share Price Weakness

If you are wondering whether Repligen's current share price lines up with its underlying worth, you are not alone. This article walks through what the numbers actually say about value. Repligen's share price closed at US$132.14, with returns of a 4.3% decline over 7 days, 19.1% decline over 30 days, 19.6% decline year to date, 18.8% decline over 1 year, 25.1% decline over 3 years, and 33.9% decline over 5 years. This may signal that expectations or perceived risk have shifted over...
NYSE:TALO
NYSE:TALOOil and Gas

Talos Energy FY 2025 Earnings Loss Deepens Bear Narratives On Profitability Path

Talos Energy FY 2025 earnings recap Talos Energy (TALO) closed out FY 2025 with fourth quarter revenue of US$392.2 million and a basic EPS loss of US$1.19, alongside a full year trailing twelve month revenue base of about US$1.8 billion and a loss of US$2.82 per share. Over recent quarters, the company has seen quarterly revenue move from US$509.1 million in Q3 2024 to US$512.9 million in Q1 2025 and then within a US$392.2 million to US$450.0 million range through Q4 2025. Basic EPS shifted...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

CleanSpark (CLSK) Valuation Check After Wider Loss And AI Data Center Expansion Update

CleanSpark (CLSK) moved into focus after its latest quarterly report, where a wider-than-expected net loss coincided with management spotlighting a shift toward high-performance computing and AI infrastructure tied to new data center leases. See our latest analysis for CleanSpark. The share price reaction around the recent earnings and AI data center update comes against a mixed backdrop. There has been a 12.73% 7-day share price return, but a 16.00% 30-day and 22.30% 90-day share price...
NYSE:TPH
NYSE:TPHConsumer Durables

Tri Pointe Homes (TPH) Margin Compression Reinforces Bearish Earnings Narrative

Tri Pointe Homes (TPH) just posted its FY 2025 numbers with fourth quarter revenue of US$972.6 million and basic EPS of US$0.71, alongside full year trailing twelve month revenue of US$3.5 billion and EPS of US$2.73. Over the past six quarters, revenue has moved from US$1.25 billion in Q4 2024 to US$972.6 million in Q4 2025, while quarterly EPS shifted from US$1.39 to US$0.71. Investors now have to weigh these results against a trailing net margin that sits at 6.9% compared with 10.2% a year...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Assessing Himax Technologies (HIMX) Valuation After Weak Earnings And Hinted 2026 Recovery

Himax Technologies (HIMX) has put fresh numbers on the table, reporting fourth quarter 2025 revenue of US$203.08 million and net income of US$6.34 million, alongside softer full year results and cautious first quarter 2026 guidance. See our latest analysis for Himax Technologies. The latest results and cautious first quarter 2026 outlook come after a mixed share price pattern, with a 7 day share price return of 3.0% and a 90 day share price return of 4.12% contrasted by a 1 year total...
NYSE:ADNT
NYSE:ADNTAuto Components

Adient (ADNT) Valuation Check As Sculpted Soft Trim Targets Seat Design And Efficiency

Adient (ADNT) has drawn fresh attention after introducing Sculpted Soft Trim, a new seat trim product aimed at improving vehicle interior design, cutting sewing labor, and simplifying complex shapes for automaker customers. See our latest analysis for Adient. The Sculpted Soft Trim launch comes as Adient’s share price sits at US$24.79, with a 30 day share price return of 16.06% and a year to date share price return of 30.20%. This points to building momentum despite a 3 year total shareholder...
NYSE:ARES
NYSE:ARESCapital Markets

Ares Management Hire Highlights Liquidity Questions In Private Credit Valuation

Ares Management (NYSE:ARES) has appointed Michael Harper as head of portfolio management for systematic credit. The move comes as private credit faces increased scrutiny around liquidity risks after Blue Owl Capital imposed withdrawal restrictions. Investors are watching how large alternative asset managers respond to liquidity concerns across their private credit offerings. Ares Management, trading at $119.18, sits at the center of the conversation on private credit given its scale and...
NYSEAM:INFU
NYSEAM:INFUHealthcare

InfuSystem Holdings (INFU) Margin Gains Reinforce Bullish Narrative Despite Modest Revenue Growth

InfuSystem Holdings (INFU) has wrapped up FY 2025 with Q4 revenue of US$36.2 million and basic EPS of US$0.10, capping a year in which trailing twelve month revenue reached US$143.4 million and EPS came in at US$0.32. The company has seen quarterly revenue move from US$33.8 million in Q4 2024 to US$36.5 million in Q3 2025 and US$36.2 million in Q4 2025, while basic EPS shifted from US$0.04 in Q4 2024 through a low of US$0.01 loss in Q1 2025 before landing between US$0.10 and US$0.12 over the...
NYSE:YOU
NYSE:YOUSoftware

Clear Secure (YOU) Margin Compression Tests Bullish Earnings Narratives After FY 2025 Results

Clear Secure FY 2025 earnings snapshot Clear Secure (YOU) has wrapped up FY 2025 with fourth quarter revenue of US$240.8 million and basic EPS of US$0.31, alongside trailing 12 month revenue of US$900.8 million and EPS of US$1.14 that frame the latest print in a broader earnings context. Over recent periods the company has seen quarterly revenue move from US$198.4 million in Q3 2024 to US$240.8 million in Q4 2025, while basic EPS has shifted from US$0.25 to US$0.31 across the same span...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

FDA COPD Generic Exclusivity Might Change The Case For Investing In Amphastar Pharmaceuticals (AMPH)

In February 2026, Amphastar Pharmaceuticals received U.S. FDA approval for its Ipratropium Bromide HFA Inhalation Aerosol as a generic equivalent to Boehringer Ingelheim's Atrovent HFA, including 180 days of marketing exclusivity for COPD maintenance treatment. This short period of exclusivity offers Amphastar a time-limited window to build presence in the inhaled COPD market while supporting its broader mix of generic and proprietary products. Next, we’ll examine how the 180-day exclusivity...
NYSE:ABBV
NYSE:ABBVBiotechs

AbbVie Expands US Manufacturing And CLL Options With New Growth Drivers

AbbVie (NYSE:ABBV) is committing $380 million to build two advanced manufacturing facilities in the U.S. for neuroscience and obesity medicines. The new sites are expected to support next generation production using artificial intelligence and create about 300 jobs. AbbVie also received FDA approval for the first all oral, fixed duration combination regimen for chronic lymphocytic leukemia. For a company already known for its immunology and oncology portfolio, these two moves mark a...
NYSE:LTH
NYSE:LTHHospitality

Life Time Group Holdings (LTH) Margin Jump Tests Bullish Profitability Narratives

Life Time Group Holdings (LTH) closed out FY 2025 with Q4 revenue of US$745.1 million, basic EPS of US$0.56 and net income excluding extra items of US$123 million, set against a year in which trailing twelve month revenue reached US$3.0 billion, EPS was US$1.71 and net income was US$373.7 million. Over the past few quarters, the company has seen revenue move from US$663.3 million and EPS of US$0.18 in Q4 2024 to US$745.1 million and EPS of US$0.56 in Q4 2025. Trailing EPS stepped up from...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

UFP Technologies (UFPT) Earnings Growth Of 15.8% Tests Bearish Margin Concerns

UFP Technologies (UFPT) has wrapped up FY 2025 with Q4 revenue of US$148.9 million and basic EPS of US$2.28, framed by trailing twelve month revenue of US$602.8 million and EPS of US$8.87 that reflect earnings growth of 15.8% over the past year. The company has seen revenue move from US$504.4 million and EPS of US$7.69 on a trailing basis in Q4 2024 to US$602.8 million and EPS of US$8.87 by Q4 2025, which sets the scene for investors to weigh solid earnings expansion against a slightly softer...
NYSE:AOMR
NYSE:AOMRMortgage REITs

Angel Oak Mortgage REIT (AOMR) Quarterly EPS Swings Challenge Income Stability Narratives

Angel Oak Mortgage REIT (AOMR) has just posted its FY 2025 results, with Q4 total revenue of US$16.7 million and basic EPS of US$0.46, while trailing 12 month revenue came in at US$61.0 million and basic EPS at US$1.86, alongside reported earnings growth of 54% over the year. Over recent quarters the company has seen total revenue range from US$23.5 million and basic EPS of US$0.88 in Q1 2025, to US$5.9 million and basic EPS of US$0.03 in Q2, US$14.9 million and basic EPS of US$0.49 in Q3,...
NYSE:RRC
NYSE:RRCOil and Gas

Range Resources (RRC) Margin Expansion Reinforces Bullish Narratives After FY 2025 Earnings

Range Resources (RRC) has wrapped up FY 2025 with fourth quarter revenue of US$913.9 million and basic EPS of US$0.75, alongside net income excluding extra items of US$178.0 million, capping a year where trailing twelve month revenue reached US$3.1 billion and EPS came in at US$2.77. Over the past year the company has seen revenue move from US$2.4 billion to US$3.1 billion on a trailing basis, while net income excluding extra items has gone from US$265.0 million to US$658.0 million and basic...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

Oddity Tech (ODD) Margin Compression Reinforces Bearish Narrative Despite FY 2025 EPS Growth

Recent Results Set Against a Shifting Earnings Outlook Oddity Tech (NasdaqGM:ODD) has wrapped up FY 2025 with fourth quarter revenue of US$152.7 million and basic EPS of US$0.10, alongside trailing twelve month revenue of US$809.8 million and EPS of US$1.95 that sit against a 9.1% year over year earnings increase and a net margin of 13.7%. Over the past year, the company has seen quarterly revenue move from US$123.6 million in Q4 2024 to US$268.1 million in Q1 2025, US$241.1 million in Q2,...
NasdaqGS:BLMN
NasdaqGS:BLMNHospitality

Bloomin' Brands (BLMN) Q4 EPS Loss Keeps Margin Concerns In Focus For Bulls And Bears

Bloomin' Brands FY 2025 earnings snapshot Bloomin' Brands (BLMN) has wrapped up FY 2025 with Q4 revenue of US$975.2 million and a basic EPS loss of US$0.14, as net income excluding extra items came in at a loss of US$12.2 million. Over the past few quarters, revenue has ranged from US$928.8 million to US$1.05 billion while EPS has swung from a profit of US$0.50 in Q1 to a loss of US$0.54 in Q3 and a smaller loss in Q4. This combination presents a mixed picture on earnings quality and...
NasdaqGS:MORN
NasdaqGS:MORNCapital Markets

Morningstar (MORN) Valuation Check After Earnings Beat Buyback And New Retirement Products

Morningstar (MORN) has been back in focus after reporting quarterly results that exceeded analyst expectations on revenue and EPS, along with new retirement products, a leadership hire in its Direct Platform business, and a completed share repurchase. See our latest analysis for Morningstar. Despite the recent earnings beat, new retirement products, and leadership changes, Morningstar’s share price performance has been weak, with a 30 day share price return of 18.38% and a 1 year total...
NYSE:PSTL
NYSE:PSTLOffice REITs

Postal Realty Trust (PSTL) Earnings Margins Strengthen Supportive Bullish Lease Narrative

Postal Realty Trust (PSTL) has just wrapped up FY 2025 with fourth quarter revenue of US$26.0 million and basic EPS of US$0.25, alongside trailing 12 month revenue of US$95.8 million and basic EPS of US$0.58 that frame the latest numbers in a fuller earnings picture. Over the past few reporting periods, the company has seen revenue move from US$21.4 million in Q4 2024 to US$26.0 million in Q4 2025, while quarterly basic EPS shifted from US$0.17 to US$0.25, setting up this result against a...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Astec Industries (ASTE) Margin Improvement Supports Bullish Narratives Despite Thin 2.8% Profitability

Astec Industries (ASTE) has wrapped up FY 2025 with fourth quarter revenue of US$400.6 million and basic EPS of US$0.52, alongside trailing twelve month revenue of about US$1.4 billion and basic EPS of US$1.70. This gives a clearer view of full year profitability. Over recent periods the company has seen quarterly revenue move from US$291.4 million in Q3 2024 to US$359 million in Q4 2024, then to US$329.4 million, US$330.3 million, US$350.1 million and US$400.6 million through FY 2025...